Liver transplantation is the only effective therapeutic option for patients with end-stage liver disease due to primary sclerosing cholangitis (PSC). In this study, we analyzed a single center's experience with 150 consecutive PSC patients who received 174 liver allografts. Mean follow-up was 55 mon
Outcome of Patients Undergoing Liver Transplantation for Primary Sclerosing Cholangitis
β Scribed by A. R. MacLean
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 120 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease in children. The aim of this study was to determine the characteristics and outcomes of children with PSC who were listed for liver transplantation (LT). Children who underwent transplantation for PSC according to the Studies o
Recurrence of primary sclerosing cholangitis (PSC) following liver transplantation has been suggested; however, it has not been fully defined because of numerous complicating factors and the lack of diagnostic criteria. In the present study, we investigated the recurrence of PSC by developing strict